COMMUNIQUÉS West-GlobeNewswire

ECM Therapeutics Reports Promising Results in Fistula Repair
13/10/2026
Interim findings highlight ECM hydrogel’s potential for patients with limited treatment options WARRENDALE, Pa., Oct. 13, 2026 (GLOBE NEWSWIRE) -- ECM Therapeutics, Inc. today announced early clinical results suggesting [...]
Akari Therapeutics Appoints Accomplished Oncology and ADC Deal Executive Vatnak Vat-Ho as Chief Business Officer to Drive Strategic Growth and Partnering
13/10/2026
Mr. Vat-Ho's appointment adds more than 20 years of oncology, biopharma and capital markets experience, including senior roles in transactions totaling more than $25 billion in aggregate value Mr. Vat-Ho brings highly [...]
Omada Health to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 5, 2026
13/10/2026
SAN FRANCISCO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its third quarter 2026 results on Thursday, November 5, [...]
Alembic Therapeutics LLC Announces Availability of Clonidine Hydrochloride Tablets, 0.05mg
13/10/2026
BEDMINSTER, N.J., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics LLC announces the launch of Clonidine Hydrochloride Tablets, 0.05mg, in a 60-count bottle. Clonidine hydrochloride is an FDA-approved prescription [...]
Applied Biologics Announces First Patient Treated in Phase 3 BIOxHEAL™ Clinical Trial
13/10/2026
First patient receives investigational biologic in multicenter randomized controlled trial evaluating BIOxHEAL for chronic diabetic foot ulcers SCOTTSDALE, Ariz., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, LLC [...]
SafeSpace Global Appoints former Amazon, Google and YouTube Executive as Chief Operating Officer to Accelerate Next Phase of AI-Powered Growth
13/10/2026
Technology Industry Veteran Prashant “Shaun” Kancherla Brings More than a Decade of Global Leadership and a Track Record of Delivering Operating Efficiencies KNOXVILLE, Tenn., Oct. 13, 2026 (GLOBE NEWSWIRE) -- SafeSpace [...]
Daré Bioscience Launches “CEO Corner” Video Series to Highlight the Company’s Pipeline of Women’s Health Innovations, Corporate Strategy and Opportunities
13/10/2026
New video series featuring Founder, President and CEO Sabrina Martucci Johnson will provide investors with insights into Daré Bioscience’s growing commercial portfolio, clinical pipeline and strategic priorities Access [...]
ProText Mobility Chairman Confirms 831.3 Million Common Shares in SEC Filing — Chairman and CEO Reaffirm Zero Preferred Conversions, Unified Management Philosophy and Shareholder Solidarity
13/10/2026
Guided by Ubuntu — “I Am Because You Are” — Chairman Dr. Ahmed Jamaloodeen reinforces his substantial personal investment, long-term ownership commitment and shared vision with TXTM shareholders as the Company advances [...]
Acentra Health’s Chief Health and Informatics Officer Ryan Bosch, MD, FACP Named Fellow of the American College of Health Data Management
13/10/2026
Recognition honors Dr. Bosch’s leadership in population health, clinical informatics, and healthcare innovation MCLEAN, Va., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health solutions company [...]
Transactions in connection with share buy-back program
13/10/2026
Company announcement no. 39 - 26 13 October 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Travelan® Phase 2 Study Results Published
13/10/2026
MELBOURNE, Australia, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) today announced that data from its Phase 2 clinical trial of once-daily oral Travelan ® has been published in the Nature [...]
Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (CT1812) Through 2045
13/10/2026
- An additional five years of patent protection may be possible through a standard extension - PURCHASE, N.Y., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , (the “Company” or “Cognition”) (NASDAQ: [...]
Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026
13/10/2026
New sponsored and independent research evaluates clinical utility, patient follow-up, and diagnostic test sequencing LOUISVILLE, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading [...]
Le Gala Reale Di Savoia fera ses débuts à Montréal au profit de la Fondation Point d’Appui
13/10/2026
Une soirée d’exception réunissant philanthropie, histoire et impact communautaire en présence de Son Altesse Royale le prince Emanuele Filiberto de Savoie MONTRÉAL, 13 oct. 2026 (GLOBE NEWSWIRE) -- Une tradition [...]
Gala Reale di Savoia to make It’s Montreal debut in support of Point d’Appui Foundation
13/10/2026
A distinguished evening that will unite philanthropy, history and community impact in the presence of His Royal Highness Prince Emanuele Filiberto di Savoia MONTREAL, Oct. 13, 2026 (GLOBE NEWSWIRE) -- A centuries-old [...]
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2026
13/10/2026
Company Announcement Net sales of DARZALEX ® in the third quarter of 2026 totaled USD 4,239 million Genmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc [...]
BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer
13/10/2026
AHEAD-MERIT Phase 2/3 clinical trial did not meet its first dual primary endpoint of progression-free survival for the mRNA cancer immunotherapy candidate BNT113 plus pembrolizumab compared with pembrolizumab alone The [...]
Leo International Precision Health AG implements capital increase from company reserves
13/10/2026
Planegg / Martinsried, October 13, 2026 – Leo International Precision Health AG (“LIPH”, ticker symbol: LEOW), a holding company building a global integrated AI-driven healthcare ecosystem, is implementing the technical [...]
Zelluna ASA: Invitation to Third Quarter 2026 Results Webcast Including ZIMA-101 Clinical Progress Update
13/10/2026
Oslo, 13 October 2026 – Zelluna (OSE: ZLNA), a clinical-stage biotechnology Company pioneering allogeneic, off-the-shelf T-cell receptor-based natural killer (TCR-NK) cell therapies for solid cancers, will publish its [...]

Pages